Methods of treatment using IL-6
US6284237A · kind A · utility
1Cited by
6References
8Claims
0Family size
Inventors
Key dates
| Filing date | Apr 6, 1994 |
| Grant date | Sep 4, 2001 |
| Priority date | — |
| Expiry date | Apr 6, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/395
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
IL-6 is produced via recombinant DNA techniques. The peptide is useful in the treatment of disorders characterized by deficiencies in hematopoietic cells and in combination with other hematopoietins in cancer therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.